TC Energy Corp
TRP
Enbridge Inc
ENB
The Toronto-Dominion Bank
TD
4
BCE Inc
BCE
5
Emera Inc
EMA
CA Stock MarketDetailed Quotes
APS Aptose Biosciences Inc
- 2.910
- -0.070-2.35%
15min DelayMarket Closed Apr 11 16:00 ET
7.43MMarket Cap-0.06P/E (TTM)
2.910High2.900Low1.15KVolume2.910Open2.980Pre Close3.36KTurnover60.90052wk High0.06%Turnover Ratio2.55MShares1.98052wk Low-52.325EPS TTM5.92MFloat Cap1425600.000Historical HighLossP/E (Static)2.04MShs Float1.980Historical Low-52.325EPS LYR0.34%Amplitude--Dividend TTM-1.16P/B1Lot Size--Div YieldTTM
Aptose Biosciences Inc Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 19.32%-35.98M | 12.95%-8.06M | 1.52%-10.38M | 57.21%-5.78M | -4.08%-11.76M | -37.96%-44.59M | -7.03%-9.26M | -50.97%-10.54M | -91.61%-13.5M | -17.18%-11.3M |
| Net income from continuing operations | 50.34%-25.43M | 86.74%-1.59M | 39.26%-6.95M | 48.67%-7.25M | 29.51%-9.64M | -22.44%-51.21M | -19.55%-11.96M | -17.08%-11.45M | -33.73%-14.13M | -19.12%-13.68M |
| Operating gains losses | ---610K | ---686K | ---- | --66K | --10K | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -13.30%404K | -11.82%97K | -13.51%96K | -10.53%102K | -16.79%109K | -11.74%466K | 10.00%110K | -21.28%111K | -19.15%114K | -10.27%131K |
| Unrealized gains and losses of investment securities | ---- | ---- | --0 | -50.00%1K | 75.00%-1K | ---- | ---- | -114.29%-1K | --2K | ---4K |
| Remuneration paid in stock | -70.98%1.06M | -86.13%57K | -102.17%-13K | -73.08%207K | -56.83%809K | -29.84%3.65M | -52.26%411K | -43.11%599K | -1.28%769K | -25.46%1.87M |
| Other non cashItems | -20.51%-376K | -30.09%-428K | 171.43%15K | -84.48%9K | 40.00%28K | 45.36%-312K | 51.11%-329K | -125.61%-21K | 141.67%58K | 600.00%20K |
| Change In working capital | -492.35%-11.03M | -320.51%-5.52M | -1,678.92%-3.52M | 443.53%1.09M | -971.95%-3.08M | -34.91%2.81M | 137.06%2.5M | -85.28%223K | -112.34%-317K | 142.94%353K |
| -Change in prepaid assets | -180.84%-211K | -248.31%-1.34M | 1,017.24%324K | 80.06%560K | -3.91%246K | 50.87%261K | 73.72%-385K | -96.48%29K | -48.08%311K | 19.63%256K |
| -Change in payables and accrued expense | -474.97%-10.84M | -280.95%-5.31M | -935.21%-2.97M | 207.39%567K | -2,511.54%-3.14M | -32.24%2.89M | 45.30%2.94M | -66.16%355K | -124.86%-528K | 114.05%130K |
| -Change in other current assets | 108.75%30K | 333.33%791K | -1,645.45%-768K | 247.27%81K | -177.89%-74K | -176.61%-343K | -480.90%-339K | 80.44%-44K | -175.00%-55K | 196.88%95K |
| -Change in other current liabilities | ---- | ---- | 4.27%-112K | -164.44%-119K | 10.16%-115K | ---- | ---- | 12.69%-117K | 66.42%-45K | 10.49%-128K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 19.32%-35.98M | 12.95%-8.06M | 1.52%-10.38M | 57.21%-5.78M | -4.08%-11.76M | -37.96%-44.59M | -7.03%-9.26M | -50.97%-10.54M | -91.61%-13.5M | -17.18%-11.3M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -99.82%18K | 0 | 0 | 202.50%2.01M | 32.74%-1.99M | -66.87%9.96M | -88.97%1.94M | 355.08%12.95M | -119.47%-1.96M | -139.44%-2.96M |
| Net PPE purchase and sale | 162.07%18K | --0 | --0 | 158.62%17K | --1K | -20.83%-29K | --0 | --0 | -20.83%-29K | --0 |
| Net investment purchase and sale | --0 | --0 | --0 | 203.16%1.99M | 32.70%-1.99M | -66.80%9.99M | -88.97%1.94M | 355.08%12.95M | -119.14%-1.93M | -139.44%-2.96M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -99.82%18K | --0 | --0 | 202.50%2.01M | 32.74%-1.99M | -66.87%9.96M | -88.97%1.94M | 355.08%12.95M | -119.47%-1.96M | -139.44%-2.96M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 383.56%33.41M | 696.84%6.81M | 104.16%10.01M | 330.62%4.75M | 23,594.00%11.85M | 5,856.90%6.91M | 1,574.51%854K | 23,242.86%4.9M | 3,706.90%1.1M | 233.33%50K |
| Net issuance payments of debt | --10M | --0 | --10M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net common stock issuance | 239.86%23.39M | 641.16%6.63M | --0 | 344.63%4.93M | 34,691.18%11.83M | 6,712.87%6.88M | 1,652.94%894K | 22,966.67%4.84M | 3,724.14%1.11M | --34K |
| Proceeds from stock option exercised by employees | -3.45%28K | --2K | -38.46%8K | --0 | 12.50%18K | 93.33%29K | --0 | --13K | --0 | 6.67%16K |
| Net other financing activities | ---- | ---- | ---- | -3,440.00%-177K | ---- | ---- | ---- | --45K | ---5K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 383.56%33.41M | 696.84%6.81M | 104.16%10.01M | 330.62%4.75M | 23,594.00%11.85M | 5,856.90%6.91M | 1,574.51%854K | 23,242.86%4.9M | 3,706.90%1.1M | 233.33%50K |
| Net cash flow | ||||||||||
| Beginning cash position | -74.97%9.25M | -49.35%7.96M | -0.83%8.33M | -67.73%7.35M | -74.97%9.25M | -5.48%36.97M | -43.84%15.72M | -79.02%8.4M | -38.47%22.76M | -5.48%36.97M |
| Current changes in cash | 90.82%-2.55M | 80.59%-1.26M | -105.03%-368K | 106.86%985K | 86.58%-1.91M | -1,195.33%-27.72M | -172.07%-6.47M | 160.81%7.32M | -571.10%-14.36M | -568.80%-14.21M |
| Effect of exchange rate changes | --0 | --0 | --0 | 66.67%-1K | -75.00%1K | 150.00%2K | -116.67%-1K | 114.29%1K | 40.00%-3K | 100.00%4K |
| End cash Position | -27.51%6.71M | -27.51%6.71M | -49.35%7.96M | -0.83%8.33M | -67.73%7.35M | -74.97%9.25M | -74.97%9.25M | -43.84%15.72M | -79.02%8.4M | -38.47%22.76M |
| Free cash from | 19.36%-35.98M | 12.90%-8.07M | 1.52%-10.38M | 57.30%-5.78M | -4.08%-11.76M | -37.94%-44.62M | -7.03%-9.26M | -50.97%-10.54M | -91.37%-13.53M | -17.18%-11.3M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Dividend Kings of Canada Dividend Kings of Canada
Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.
Unlock Now